Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

The repair of the mutation leads to earlier fruit yield. Scale: 7.5 cm. Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...